View in EDS HTML Full Text PDF Full Text

Final data from the German AHEAD study: effectiveness and safety of octocog alfa and rurioctocog alfa pegol for hemophilia A in a real-world setting.

Saved in:
Bibliographic Details
Title: Final data from the German AHEAD study: effectiveness and safety of octocog alfa and rurioctocog alfa pegol for hemophilia A in a real-world setting.
Authors: Klamroth R; Department for Internal Medicine, Vascular Medicine and Haemostaseology, Vivantes Klinikum im Friedrichshain, Landsberger Allee 49, 10249 Berlin, Germany.; Institute for Experimental Hematology and Transfusion Medicine, Bonn University Clinic, Bonn, Germany., Kurnik K; Department of Pediatrics, Pediatric Haemophilia Center, Dr. von Hauner Children's Hospital, LMU University Hospital Munich, Munich, Germany., Wenning S; SRH Kurpfalzkrankenhaus, Heidelberg, Germany., Escuriola-Ettingshausen C; Hämophilie-Zentrum Rhein Main GmbH, Frankfurt/Main, Germany., Regensburger S; Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany., Tang L; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Gu J; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Guerra R; Takeda Development Center Americas, Inc., Cambridge, MA, USA., Oldenburg J; Institute for Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Medical Faculty, University of Bonn, Bonn, Germany.
Source: Therapeutic advances in hematology [Ther Adv Hematol] 2026 May 03; Vol. 17, pp. 20406207261419337. Date of Electronic Publication: 2026 May 03 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42111118
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Final data from the German AHEAD study: effectiveness and safety of octocog alfa and rurioctocog alfa pegol for hemophilia A in a real-world setting.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Klamroth+R%22">Klamroth R</searchLink>; Department for Internal Medicine, Vascular Medicine and Haemostaseology, Vivantes Klinikum im Friedrichshain, Landsberger Allee 49, 10249 Berlin, Germany.; Institute for Experimental Hematology and Transfusion Medicine, Bonn University Clinic, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Kurnik+K%22">Kurnik K</searchLink>; Department of Pediatrics, Pediatric Haemophilia Center, Dr. von Hauner Children's Hospital, LMU University Hospital Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Wenning+S%22">Wenning S</searchLink>; SRH Kurpfalzkrankenhaus, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Escuriola-Ettingshausen+C%22">Escuriola-Ettingshausen C</searchLink>; Hämophilie-Zentrum Rhein Main GmbH, Frankfurt/Main, Germany.<br /><searchLink fieldCode="AU" term="%22Regensburger+S%22">Regensburger S</searchLink>; Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Tang+L%22">Tang L</searchLink>; Takeda Pharmaceuticals International AG, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gu+J%22">Gu J</searchLink>; Takeda Development Center Americas, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Guerra+R%22">Guerra R</searchLink>; Takeda Development Center Americas, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Oldenburg+J%22">Oldenburg J</searchLink>; Institute for Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Medical Faculty, University of Bonn, Bonn, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101549589%22">Therapeutic advances in hematology</searchLink> [Ther Adv Hematol] 2026 May 03; Vol. 17, pp. 20406207261419337. <i>Date of Electronic Publication: </i>2026 May 03 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101549589 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2040-6207 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220406207%22">20406207 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Hematol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42111118
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/20406207261419337
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 20406207261419337
    Titles:
      – TitleFull: Final data from the German AHEAD study: effectiveness and safety of octocog alfa and rurioctocog alfa pegol for hemophilia A in a real-world setting.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Klamroth R
      – PersonEntity:
          Name:
            NameFull: Kurnik K
      – PersonEntity:
          Name:
            NameFull: Wenning S
      – PersonEntity:
          Name:
            NameFull: Escuriola-Ettingshausen C
      – PersonEntity:
          Name:
            NameFull: Regensburger S
      – PersonEntity:
          Name:
            NameFull: Tang L
      – PersonEntity:
          Name:
            NameFull: Gu J
      – PersonEntity:
          Name:
            NameFull: Guerra R
      – PersonEntity:
          Name:
            NameFull: Oldenburg J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 05
              Text: 2026 May 03
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2040-6207
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Therapeutic advances in hematology
              Type: main
ResultId 1